Post-Marketing Clinical Study to Assess Efficacy and Safety of Dexmedetomidine in Post-Operative Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

85

Participants

Timeline

Start Date

November 30, 2005

Primary Completion Date

August 31, 2006

Study Completion Date

August 31, 2006

Conditions
Conscious Sedation
Interventions
DRUG

Dexmedetomidine

DRUG

Propofol

Trial Locations (13)

Unknown

Hirosaki University Hospital, Hirosaki-shi

Kyushu University Hospital, Higashiku

Kagoshima University Medical and Dental Hospital, Kagoshima

Kyoto University Hospital, Sakyoku

Nagasaki University Hospital of Medicine and Dentistry, Nagasaki

Okayama University Hospital of Medicine and Dentistry, Okayama

Osaka City General Hospital, Miyakojima-ku

Kinki University Hospital, Osaka-Sayama-Shi

Osaka University Hospital, Suita

Hamamatsu University Hospital, Hamamatsu

Nippon Medical School Hospital, Bunkyo-ku

Showa University Hospital, Shinagawa-ku

Tokyo Women's Medical University Hospital, Shinjuku-ku

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Maruishi Pharmaceutical

INDUSTRY

lead

Hospira, now a wholly owned subsidiary of Pfizer

INDUSTRY

NCT00318955 - Post-Marketing Clinical Study to Assess Efficacy and Safety of Dexmedetomidine in Post-Operative Patients | Biotech Hunter | Biotech Hunter